Mayinglong Pharmaceutical Group Company Limited manufactures and markets traditional Chinese medicines and western medicines for the treatment of hemorrhoids and cough.

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2024

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Mayinglong Pharmaceutical A (600993 CH)

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2024

Announcement on Release of Pledge and Re-pledge of Some Shares Held by Controlling Shareholders

Announcement on Release of Pledge and Re-pledge of Some Shares Held by Controlling Shareholders

Announcement on Extending the Duration of Industrial Investment Fund

Announcement on Obtaining Drug Registration Certificate by Its Wholly-owned Subsidiary

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)